Zenlabs Ethica Limited Share Price

Zenlabs Ethica Limited is an India-based pharmaceutical contract manufacturing company. The Company develops, markets and exports a range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-bacterial Drugs, Nutraceuticals, and others. The Company operates in the pharmaceutical’s formulations segment, which primarily includes marketing and distribution of pharmaceutical products. Its divisions include Zenlabs, Coles Pharma and Mega Star. Its product categories include analgesics & anti-inflammatory, skin preparations, neurological disorders, eye, ear and nasal drops, anti-diabetic, anti-depressant, anti-infective, anti-emetic, steroid and anabolic steroids, antihypertensive drugs, anti-allergic, anti-cold and cough syrup, nutraceuticals, antacid, enzymes and appetite stimulant, ayurvedic preparation, git disorders, soap, and other pharmaceutical drugs. Its brands include RBC Red Super Active and Zenovit.As of 26 May 2026, Zenlabs Ethica Limited share price is ₹32.99. The stock opened at ₹30.99, compared to its previous close of ₹30.07. During today's trading session, Zenlabs Ethica Limited share price moved in the range of ₹30.49 to ₹35.50, with an average price of ₹32.99 for the day. Looking at its last 52-week, the stock has touched a low of ₹30.49 and a high of ₹35.50.

The market capitalization of Zenlabs Ethica Limited is ₹20 Crs, with a P/E ratio of -10.6 and a dividend yield of 0.00%.